Es gab 50 kürzliche Insider-Transaktionen für iRhythm Technologies, Inc. (IRTC), darunter 22 Käufe und 26 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $27.65K und die gesamten Insider-Verkäufe auf $17.5M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Rodda Julianne, Smith Mervin, Patten Jason H. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — IRTC
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-31 |
Rodda Julianne |
EVP, Chief People Officer |
Unbekannt |
- |
- |
- |
20,313 |
| 2026-03-16 |
Smith Mervin |
EVP Strategic Business Ops |
Informierter Verkauf |
2,585 |
$114.30 |
$295.47K |
23,027 |
| 2026-03-12 |
Patten Jason H |
Director |
Unbekannt |
- |
- |
- |
- |
| 2026-03-12 |
Patten Jason H |
Director |
RSU-Zuteilung |
2,218 |
- |
- |
4,436 |
| 2026-03-02 |
Blackford Quentin S. |
President and CEO |
Informierter Verkauf |
5,423 |
$128.44 |
$696.55K |
204,155 |
| 2026-03-02 |
Murphy Patrick Michael |
Cbo and CLO |
Informierter Verkauf |
1,139 |
$128.45 |
$146.3K |
63,203 |
| 2026-03-02 |
Patterson Chad |
Chief Comm & Product Officer |
Informierter Verkauf |
3,030 |
$128.45 |
$389.19K |
58,164 |
| 2026-03-02 |
Shrishrimal Sumi |
EVP, Chief Risk Officer |
Informierter Verkauf |
978 |
$128.44 |
$125.62K |
41,870 |
| 2026-03-02 |
Wilson Daniel G. |
Chief Financial Officer |
Informierter Verkauf |
1,261 |
$128.45 |
$161.98K |
35,660 |
| 2026-03-02 |
Rosenbaum Marc Wade |
Chief Accounting Officer |
Informierter Verkauf |
417 |
$128.45 |
$53.56K |
16,706 |
| 2026-03-02 |
Turakhia Minang |
Chief Med/sci Ofcr EVP Advtech |
Informierter Verkauf |
1,230 |
$128.45 |
$158K |
54,906 |
| 2026-03-02 |
Smith Mervin |
EVP Strategic Business Ops |
Informierter Verkauf |
600 |
$128.45 |
$77.07K |
25,612 |
| 2026-02-25 |
Blackford Quentin S. |
President and CEO |
Informierter Verkauf |
25,540 |
$135.42 |
$3.46M |
186,126 |
| 2026-02-25 |
Murphy Patrick Michael |
Cbo and CLO |
Informierter Verkauf |
7,805 |
$135.42 |
$1.06M |
60,536 |
| 2026-02-25 |
Patterson Chad |
Chief Comm & Product Officer |
Informierter Verkauf |
8,967 |
$135.42 |
$1.21M |
51,738 |
| 2026-02-25 |
Shrishrimal Sumi |
EVP, Chief Risk Officer |
Informierter Verkauf |
6,217 |
$135.42 |
$841.9K |
39,182 |
| 2026-02-25 |
Wilson Daniel G. |
Chief Financial Officer |
Informierter Verkauf |
5,188 |
$135.42 |
$702.55K |
30,694 |
| 2026-02-25 |
Rosenbaum Marc Wade |
Chief Accounting Officer |
Informierter Verkauf |
4,797 |
$135.42 |
$649.6K |
15,014 |
| 2026-02-25 |
Turakhia Minang |
Chief Med/sci Ofcr EVP Advtech |
Informierter Verkauf |
7,804 |
$135.42 |
$1.06M |
48,899 |
| 2026-02-25 |
Smith Mervin |
EVP Strategic Business Ops |
Informierter Verkauf |
4,041 |
$135.42 |
$547.23K |
20,275 |
| 2026-02-25 |
Lawrence Brian Lee |
Chief Technology Officer |
RSU-Zuteilung |
6,689 |
- |
- |
21,168 |
| 2026-02-25 |
Blackford Quentin S. |
President and CEO |
RSU-Zuteilung |
31,842 |
- |
- |
217,968 |
| 2026-02-25 |
Murphy Patrick Michael |
Cbo and CLO |
RSU-Zuteilung |
7,024 |
- |
- |
67,560 |
| 2026-02-25 |
Patterson Chad |
Chief Comm & Product Officer |
RSU-Zuteilung |
10,870 |
- |
- |
62,608 |
| 2026-02-25 |
Shrishrimal Sumi |
EVP, Chief Risk Officer |
RSU-Zuteilung |
5,518 |
- |
- |
44,700 |
| 2026-02-25 |
Wilson Daniel G. |
Chief Financial Officer |
RSU-Zuteilung |
8,361 |
- |
- |
39,055 |
| 2026-02-25 |
Rosenbaum Marc Wade |
Chief Accounting Officer |
RSU-Zuteilung |
2,508 |
- |
- |
17,522 |
| 2026-02-25 |
Turakhia Minang |
Chief Med/sci Ofcr EVP Advtech |
RSU-Zuteilung |
10,034 |
- |
- |
58,933 |
| 2026-02-25 |
Smith Mervin |
EVP Strategic Business Ops |
RSU-Zuteilung |
6,689 |
- |
- |
26,964 |
| 2026-02-25 |
Freeman Sean Clinton |
EVP, Strategy & Corp Devt |
RSU-Zuteilung |
7,525 |
- |
- |
14,286 |
| 2026-02-24 |
Rosenbaum Marc Wade |
Chief Accounting Officer |
Informierter Verkauf |
280 |
$140.91 |
$39.45K |
10,601 |
| 2026-02-24 |
Smith Mervin |
EVP Strategic Business Ops |
Informierter Verkauf |
732 |
$140.91 |
$103.15K |
15,106 |
| 2026-02-24 |
Blackford Quentin S. |
President and CEO |
RSU-Zuteilung |
46,687 |
- |
- |
211,666 |
| 2026-02-24 |
Murphy Patrick Michael |
Cbo and CLO |
RSU-Zuteilung |
15,060 |
- |
- |
68,341 |
| 2026-02-24 |
Patterson Chad |
Chief Comm & Product Officer |
RSU-Zuteilung |
17,318 |
- |
- |
60,705 |
| 2026-02-24 |
Shrishrimal Sumi |
EVP, Chief Risk Officer |
RSU-Zuteilung |
11,294 |
- |
- |
45,399 |
| 2026-02-24 |
Wilson Daniel G. |
Chief Financial Officer |
RSU-Zuteilung |
9,412 |
- |
- |
35,882 |
| 2026-02-24 |
Rosenbaum Marc Wade |
Chief Accounting Officer |
RSU-Zuteilung |
9,210 |
- |
- |
19,811 |
| 2026-02-24 |
Turakhia Minang |
Chief Med/sci Ofcr EVP Advtech |
RSU-Zuteilung |
15,060 |
- |
- |
56,703 |
| 2026-02-24 |
Smith Mervin |
EVP Strategic Business Ops |
RSU-Zuteilung |
9,210 |
- |
- |
24,316 |
| 2026-02-23 |
Talwalkar Abhijit Y |
Director |
Optionsausübung (Verkauf) |
5,312 |
$10.71 |
$56.89K |
5,312 |
| 2025-12-02 |
Murphy Patrick Michael |
Cbo and CLO |
Informierter Verkauf |
2,478 |
$184.83 |
$458.01K |
53,281 |
| 2025-12-02 |
Patterson Chad |
Chief Comm & Product Officer |
Informierter Verkauf |
280 |
$184.83 |
$51.75K |
43,387 |
| 2025-11-28 |
Shrishrimal Sumi |
EVP, Chief Risk Officer |
RSU-Zuteilung |
73 |
$119.55 |
$8.73K |
34,105 |
| 2025-11-28 |
Rosenbaum Marc Wade |
Chief Accounting Officer |
RSU-Zuteilung |
2 |
$119.55 |
$239.10 |
10,881 |
| 2025-11-28 |
Turakhia Minang |
Chief Med/sci Ofcr EVP Advtech |
RSU-Zuteilung |
250 |
$74.72 |
$18.68K |
41,643 |
| 2025-11-10 |
Talwalkar Abhijit Y |
Director |
Optionsausübung (Verkauf) |
5,312 |
$10.71 |
$56.89K |
10,624 |
| 2025-11-03 |
Blackford Quentin S. |
President and CEO |
Informierter Verkauf |
14,059 |
$182.94 |
$2.57M |
164,979 |
| 2025-10-31 |
Wilson Daniel G. |
Chief Financial Officer |
Informierter Verkauf |
8,000 |
$207.44 |
$1.66M |
26,470 |
| 2025-09-03 |
Wilson Daniel G. |
Chief Financial Officer |
Informierter Verkauf |
5,000 |
$175.00 |
$875K |
34,470 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
